News and Events
- 5 October 2023
Meet new Chemspace CEO – Dr. Olga Tarkhanova!
Please welcome our new CEO – Olga Tarkhanova, PhD!
- 3 October 2023
Analogs to New Biological Tool Compounds - 28
Here comes a new post in our series inspired by Drug Hunter’s “Molecules of the Month”!
Today it is DNL343 - an oral eIF2B activator in Phase II/III for the treatment of amyotrophic lateral sclerosis (ALS). - 1 October 2023
Chemspace Monthly Digest. September 2023
Missed the Chemspace news and highlights for September?
Here is a comprehensive summary of all our posts for this summer month!
- 28 September 2023
Building Blocks for Analogs of Momelotinib
This month Momelotinib (OJJAARA©) was approved by FDA as a drug for the treatment of myelofibrosis in adults with anemia.
- 26 September 2023
Announcement about possible delays from Chinese vendors
We would like to let you know about possible delays from Chinese vendors that might be in place for the next week.
We sincerely apologize for any inconvenience! - 23 September 2023
Meet Weekend Article about a New Method SILVR!
The new weekend article is here! Follow the link and read about a new method for conditioning an existing diffusion-based equivariant generative model without retraining!
- 21 September 2023
Chemspace & Arrayjet Webinar. Recording
Thanks to everyone for joining the Chemspace & Arrayjet Webinar ’Small Molecule Microarrays for Drug Discovery’ presented by Dr. Adam Buckle, Chief Scientific Officer at Arrayjet. Hosted by Oleksii Gavrylenko, our Chief Operating Officer.
For those who didn’t have a chance to connect, the recording is already available on the Chemspace YouTube channel!
- 19 September 2023
Join the Chemspace & Arrayjet Webinar TOMORROW!
Join the Chemspace & Arrayjet Webinar ’Small Molecule Microarrays for Drug Discovery’, which will take place TOMORROW, September 21st at 4 PM (CET) | 7 AM (PST)!
The speaker is Dr. Adam Buckle, Chief Scientific Officer at Arrayjet. Hosted by Oleksii Gavrylenko, our Chief Operating Officer!
- 18 September 2023
Biologics for Research – Glucagon-like Peptide-1 Receptor
We continue our series of posts in the Biologics campaign! Today, we focus on the glucagon-like peptide-1 receptor (GLP-1R).
At Chemspace, we offer various GLP-1R-related proteins, peptides, RNAs, highly selective antibodies, and kits!
- 14 September 2023
Bioisosteres of a meta-Substituted Benzene
Discover Chemspace meta-substituted benzene bioisosteres – a library of 260 in-stock compounds that can mimic phenyl ring properties and potentially enhance physicochemical and pharmacokinetic characteristics of molecules in the drug development process.
- 12 September 2023
General Pre-Plated Library Update! Now more than 623K!
Latest news! We have a library update, now more than 623 thousand compounds in one place – a great starting point for your research projects! Check them out on the product page!
- 10 September 2023
Explore Freedom Space 3.0 and Enamine REAL at once!
Great update! Now you can explore Enamine REAL and Freedom Space 3.0 simultaneously!
- 9 September 2023
Meet CS Team – Account Manager Tetiana Herman!
Today we would like you to meet our Account Manager – Tetiana Herman. Follow the link to get to know her better!
- 7 September 2023
Join the Chemspace & Arrayjet Webinar!
Join the Chemspace & Arrayjet Webinar ’Small Molecule Microarrays for Drug Discovery’, which will take place at 4 pm | 7 am (PST) on September 21st, 2023.
The speaker is Dr. Adam Buckle, Chief Scientific Officer at Arrayjet. Hosted by Oleksii Gavrylenko, our Chief Operating Officer!
- 5 September 2023
Join the Chemspace Webinar Tomorrow!
Join our webinar dedicated to Machine Learning approaches for the creation and exploration of chemical spaces, which will take place TOMORROW, September 7th!
- 3 September 2023
Analogs to New Biological Tool Compounds - 27
Here comes a new post in our series inspired by Drug Hunter’s “Molecules of the Month”!
Today it is JNJ-54175446 - an oral P2X7R antagonist in Phase II for major depressive disorder (MDD). - 31 August 2023
Compound Sourcing with Chemspace!
We at Chemspace provide a one-stop shop for your compound purchasing campaign, and we would be happy to assist with it!
- 29 August 2023
Join the Chemspace Webinar!
Join our webinar dedicated to Machine Learning approaches for the creation and exploration of chemical spaces!
- 27 August 2023
Chemspace at EFMC-ASMC 2023 in Zagreb!
We are excited to announce that Rita Gaidar, our Director of Business Development will be attending EFMC-ASMC 2023 in Zagreb, Croatia.
She will present the poster dedicated to a new AI-driven approach to hit identification (poster session №1, P079). - 26 August 2023
Small-molecule discovery through DNA-encoded libraries
DNA-encoded library (DEL) is a powerful and broadly applicable small-molecule discovery method that has been increasingly applied to the discovery of chemical probes and novel clinical candidates.
- 20 August 2023
Dr. Olga Tarkhanova at ACS Fall 2023 in San Francisco
Dr. Olga Tarkhanova at ACS Fall 2023 in San Francisco presenting on Machine Learning Approaches for the Creation and Exploration of Chemical Spaces.
- 17 August 2023
Stay curious, stay informed: Subscribe to Chemspace Newsletter!
Introducing our newsletter - your gateway to the latest updates, news, and ideas from the world of chemistry, biology, and Chemspace!
- 16 August 2023
Bioisosteres of a tert-Butyl Group
Introducing our new set of Building Blocks – the most prominent bioisosteres of the tert-butyl group for marketed drugs and drug candidates! We offer 160 in-stock compounds that can mimic such moiety!
- 14 August 2023
Meet Dr. Olga Tarkhanova at the ACS 2023 Fall Symposium!
We are pleased to remind you that Dr. Olga Tarkhanova will be having a talk tomorrow at the ACS Fall Symposium “Taking a Deep Dive into Chemical Space”. She will be presenting on Machine Learning Approaches for the Creation and Exploration of Chemical Spaces.
- 12 August 2023
Analogs to New Biological Tool Compounds - 26
Here comes a new post in our series inspired by Drug Hunter’s “Molecules of the Month”!
Today it is FLX475 - an oral CCR4 antagonist in Phase II trials for immuno-oncology.